Predictors of immunosuppressive regulatory T lymphocytes in healthy women

Journal of Cancer Epidemiology

Volumn , Issue , 2012, Pages

  Hampras, Shalaka S ^a   Nesline, Mary ^a   Wallace, Paul K ^a   Odunsi, Kunle ^a   Furlani, Nicholas ^b   Davis, Warren ^a   Moysich, Kirsten B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; ORAL CONTRACEPTIVE AGENT; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; CD4+ CD25+ T LYMPHOCYTE; DEMOGRAPHY; DIET; EDUCATIONAL STATUS; EXERCISE; FEMALE; FLOW CYTOMETRY; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; LIFESTYLE; NORMAL HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REPRODUCTION; RISK FACTOR; SMOKING;

EID: 84866250882     PISSN: 16878558     EISSN: 16878566     Source Type: Journal    
DOI: 10.1155/2012/191090     Document Type: Article

References (44)

1. + T-cells from patients with type 1 diabetes. Diabetes 2005 54 1 92 99 2-s2.0-12144249838 10.2337/diabetes.54.1.92 (Pubitemid 40105099)
2. Huan J., Culbertson N., Spencer L., Bartholomew R., Burrows G. G., Chou Y. K., Bourdette D., Ziegler S. F., Offner H., Vandenbark A. A., Decreased FOXP3 levels in multiple sclerosis patients. Journal of Neuroscience Research 2005 81 1 45 52 2-s2.0-23744515175 10.1002/jnr.20522 (Pubitemid 41139109)
3. +CD 127 low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. Journal of Immunology 2008 180 9 6411 6420 2-s2.0-44449171488
4. Lin S. C., Chen K. H., Lin C. H., Kuo C. C., Ling Q. D., Chan C. H., The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. European Journal of Clinical Investigation 2007 37 12 987 996 2-s2.0-36349010693 10.1111/j.1365-2362.2007.01882.x (Pubitemid 350151184)
5. +CD25high regulatory T cell population in peripheral blood. Rheumatology 2006 45 10 1210 1217 2-s2.0-33747605602 10.1093/rheumatology/kel089 (Pubitemid 44548851)
6. Ukena S. N., Velaga S., Geffers R., Human regulatory T cells in allogeneic stem cell transplantation. Blood 2011 118 13 e82 e92
7. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. Journal of Experimental Medicine 2001 193 11 1311 1317 2-s2.0-0035806276 10.1084/jem.193.11.1311 (Pubitemid 32524781)
8. + regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs. Immunology 2007 120 4 456 466 2-s2.0-33847664579 10.1111/j.1365-2567.2006.02529. x (Pubitemid 46365011)
9. Antony P. A., Paulos C. M., Ahmadzadeh M., Akpinarli A., Palmer D. C., Sato N., Kaiser A., Heinrichs C., Klebanoff C. A., Tagaya Y., Restifo N. P., Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. Journal of Immunology 2006 176 9 5255 5266 2-s2.0-33646007658
10. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annual Review of Immunology 2004 22 531 562 2-s2.0-2442484053 10.1146/annurev.immunol. 21.120601.141122 (Pubitemid 38680433)
11. Asano M., Toda M., Sakaguchi N., Sakaguchi S., Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. Journal of Experimental Medicine 1996 184 2 387 396 2-s2.0-0029788211 (Pubitemid 26324092)
12. Mukherji B., Guha A., Chakraborty N. G., Sivanandham M., Nashed A. L., Sporn J. R., Ergin M. T., Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. Journal of Experimental Medicine 1989 169 6 1961 1976 2-s2.0-0024316373 (Pubitemid 19162959)
13. Mukherji B., Nashed A. L., Guha A., Ergin M. T., Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression. Journal of Immunology 1986 136 5 1893 1898 2-s2.0-0022614264 (Pubitemid 16119608)
14. Mukherji B., Wilhelm S. A., Guha A., Ergin M. T., Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response. Journal of Immunology 1986 136 5 1888 1892 2-s2.0-0022606308 (Pubitemid 16119607)
15. Liyanage U. K., Moore T. T., Joo H. G., Tanaka Y., Herrmann V., Doherty G., Drebin J. A., Strasberg S. M., Eberlein T. J., Goedegebuure P. S., Linehan D. C., Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. Journal of Immunology 2002 169 5 2756 2761 2-s2.0-0036721629 (Pubitemid 34921025)
16. Barnett B., Kryczek I., Cheng P., Zou W., Curiel T. J., Regulatory T cells in ovarian cancer: biology and therapeutic potential. American Journal of Reproductive Immunology 2005 54 6 369 377 2-s2.0-28644447974 10.1111/j.1600-0897.2005.00330.x (Pubitemid 41748714)
17. + effector populations in patients with squamous cell carcinoma of the head and neck. Head and Neck 2007 29 2 120 127 2-s2.0-33846484246 10.1002/hed.20490 (Pubitemid 46167778)
18. +CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. Journal of Immunology 2006 177 10 7398 7405 2-s2.0-33750807427 (Pubitemid 44715110)
19. - T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Human Immunology 2006 67 1-2 1 12 2-s2.0-33646371011 10.1016/j.humimm.2005.11.005 (Pubitemid 43673918)
20. + regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Medical Oncology 2010 27 1 29 33 2-s2.0-77949266099 10.1007/s12032-008-9165-9
21. + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 2003 98 5 1089 1099 2-s2.0-0041386189 10.1002/cncr.11618 (Pubitemid 37022112)
22. Ambrosone C. B., Nesline M. K., Davis W., Establishing a cancer center data bank and biorepository for multidisciplinary research. Cancer Epidemiology Biomarkers and Prevention 2006 15 9 1575 1577 2-s2.0-33749318608 10.1158/1055-9965.EPI-06-0628 (Pubitemid 44497088)
23. Grant J., Bourcier K., Wallace S., Pan D., Conway A., Seyfert-Margolis V., Wallace P. K., Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients. Cytometry B 2009 76 2 69 78 2-s2.0-66249119734 10.1002/cyto.b.20446
24. Sakaguchi S., Yamaguchi T., Nomura T., Ono M., Regulatory T cells and immune tolerance. Cell 2008 133 5 775 787 2-s2.0-43949105866 10.1016/j.cell.2008.05.009 (Pubitemid 351707693)
25. Kryczek I., Liu R., Wang G., Wu K., Shu X., Szeliga W., Vatan L., Finlayson E., Huang E., Simeone D., Redman B., Welling T. H., Chang A., Zou W., FOXP3 defines regulatory t cells in human tumor and autoimmune disease. Cancer Research 2009 69 9 3995 4000 2-s2.0-65949111746 10.1158/0008-5472.CAN-08-3804
26. Wolf A. M., Wolf D., Steurer M., Gastl G., Gunsilius E., Grubeck-Loebenstein B., Increase of regulatory T cells in the peripheral blood of cancer patients. Clinical Cancer Research 2003 9 2 606 612 2-s2.0-0037312480 (Pubitemid 36182591)
27. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M., Immunologic self-tolerance maintained by activated T cells expressing IL- 2 receptor α -chains (CD25): breakdown of a single mechanism of self- tolerance causes various autoimmune diseases. Journal of Immunology 1995 155 3 1151 1164 2-s2.0-0029150110
28. Sakaguchi S., Takahashi T., Nishizuka Y., Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirements of Lyt-1 effector cells of oocytes damage after adoptive transfer. Journal of Experimental Medicine 1982 156 6 1565 1576 2-s2.0-0020432846 (Pubitemid 13167405)
29. Sakaguchi S., Takahashi T., Nishizuka Y., Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirements of Lyt-1 cells in normal female mice for the prevention of oophoritis. Journal of Experimental Medicine 1982 156 6 1577 1586 2-s2.0-0020451946 (Pubitemid 13167406)
30. + CD25high regulatory T cells increases with age. Clinical and Experimental Immunology 2005 140 3 540 546 2-s2.0-20444497416 10.1111/j.1365-2249.2005.02798. x (Pubitemid 40813966)
31. + regulatory T-lymphocyte response to tobacco smoking. European Respiratory Journal 2008 31 3 555 562 2-s2.0-42949090409 10.1183/09031936.00010407
32. Brandsma C.-A., Hylkema M. N., van der Strate B. W. A., Slebos D. J., Luinge M. A., Geerlings M., Timens W., Postma D. S., Kerstjens H. A. M., Heme oxygenase-1 prevents smoke induced B-cell infiltrates: a role for regulatory T cells? Respiratory Research 2008 9, article 17 2-s2.0-41149084020 10.1186/1465-9921-9-17
33. Costabel U., Bross K. J., Reuter C., Alterations in immunoregulatory T-cell subsets in cigarette smokers. A phenotypic analysis of bronchoalveolar and blood lymphocytes. Chest 1986 90 1 39 44 2-s2.0-0022587571 (Pubitemid 16099943)
34. Vassallo R., Tamada K., Lau J. S., Kroening P. R., Chen L., Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. Journal of Immunology 2005 175 4 2684 2691 2-s2.0-23444459236 (Pubitemid 41113884)
35. Yuan X. L., Chen L., Li M. X., Dong P., Xue J., Wang J., Zhang T. T., Wang X. A., Zhang F. M., Ge H. L., Shen L. S., Xu D., Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clinical Immunology 2010 134 3 277 288 2-s2.0-76049117928 10.1016/j.clim.2009.10.005
36. + regulatory T cells. Journal of Dermatological Science 2009 53 3 216 221 2-s2.0-58649090228 10.1016/j.jdermsci. 2008.10.011
37. + regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. Journal of Immunology 2007 178 4 2572 2578 2-s2.0-33846899223 (Pubitemid 46233460)
38. + regulatory T cells by promoting their proliferation. Immunology 2006 118 1 58 65 2-s2.0-33645824326 10.1111/j.1365-2567.2006.02339.x
39. Womack J., Tien P. C., Feldman J., Shin J. H., Fennie K., Anastos K., Cohen M. H., Bacon M. C., Minkoff H., Obesity and immune cell counts in women. Metabolism 2007 56 7 998 1004 2-s2.0-34249982278 10.1016/j.metabol.2007.03.008 (Pubitemid 46890984)
40. Zeyda M., Huber J., Prager G., Stulnig T. M., Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients. Obesity 2011 19 4 743 748 2-s2.0-79953204947 10.1038/oby.2010.123
41. De Rosa V., Procaccini C., Calì G., Pirozzi G., Fontana S., Zappacosta S., La Cava A., Matarese G., A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007 26 2 241 255 2-s2.0-33847312289 10.1016/j.immuni.2007.01.011 (Pubitemid 46329441)
42. Matarese G., Procaccini C., De Rosa V., Horvath T. L., La Cava A., Regulatory T cells in obesity: the leptin connection. Trends in Molecular Medicine 2010 16 6 247 256 2-s2.0-77953477314 10.1016/j.molmed.2010.04.002
43. Lahelma E., Martikainen P., Laaksonen M., Aittomäki A., Pathways between socioeconomic determinants of health. Journal of Epidemiology and Community Health 2004 58 4 327 332 2-s2.0-1642443274 10.1136/jech.2003.011148 (Pubitemid 38406488)
44. +CD25hiCD127lo regulatory T-cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 9 1832 1841 2-s2.0-77955983228 10.1161/ATVBAHA.110.206813